Nurse Practitioner, Adult Health · Orlando, FL
NPI
1427681410
Since 2020
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
22 Underwood St
Orlando, FL, 32806
Phone (863) 226-6011
Groups this clinician bills Medicare through
Medicare paid, 2024
$44K
530 services
Medicare patients, 2024
349
Average age 76
Drug cost, 2024
$683K
1,981 prescriptions
Company payments, 2025
$2,265
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paula S Wibowo was code 99214 (office e&m - established), 324 times for 246 patients. In total Paula S Wibowo billed 530 services in 6 codes, and Medicare paid $44K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 324 | 246 | $77.93 | $25K |
| 99215 Office E&M - Established | Office | 111 | 97 | $115.24 | $13K |
| 99213 Office E&M - Established | Office | 73 | 70 | $53.52 | $3,907 |
| 99204 Office E&M - New | Office | 13 | 13 | $85.34 | $1,109 |
By year: 2022 $48K for 642 services; 2023 $50K for 630 services; 2024 $44K for 530 services.
Medicare prescription drug claims, 2024
In 2024, the drug Paula S Wibowo prescribed most often to Medicare patients was Dicyclomine Hcl, with 492 prescriptions and refills. In total Paula S Wibowo wrote 1,981 Medicare prescriptions that cost $683K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dicyclomine Hcl Generic | 492 | 1,059 | 157 | $9,322 |
| Omeprazole Generic | 400 | 1,109 | 135 | $6,850 |
| Colestipol Hcl Generic | 284 | 594 | 93 | $24K |
| Pantoprazole Sodium Generic | 135 | 374 | 53 | $1,906 |
| Famotidine Generic | 82 | 247 | 30 | $1,431 |
| Budesonide Dr Budesonide | 47 | 93 | 16 | $7,225 |
| Creon Lipase/Protease/Amylase | 36 | 46 | 13 | $111K |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 36 | 38 | Under 11 | $612 |
| Esomeprazole Magnesium Generic | 33 | 87 | 12 | $1,251 |
| Mesalamine Generic | 30 | 68 | 12 | $19K |
| Linzess Linaclotide | 29 | 49 | Under 11 | $27K |
| Cholestyramine Cholestyramine (With Sugar) | 28 | 43 | Under 11 | $5,335 |
| Humira(Cf) Pen Adalimumab | 25 | 25 | Under 11 | $183K |
| Furosemide Generic | 23 | 35 | Under 11 | $66.22 |
| Ondansetron Odt Ondansetron | 22 | 22 | Under 11 | $779 |
Brand drugs: 251 claims; generic drugs: 1,730 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paula S Wibowo $2,265 ($2,265 in general payments such as food, travel and fees) from 16 companies. The largest payer was Abbvie Inc. with $507.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 32 | $507 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 14 | $279 |
| Phathom Pharmaceuticals, Inc. PHAT | 10 | $223 |
| Gilead Sciences, Inc. GILD | 7 | $197 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 7 | $195 |
| Pfizer Inc. PFE | 10 | $181 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 7 | $148 |
| Ardelyx, Inc. ARDX | 6 | $129 |
| Mallinckrodt Hospital Products Inc. | 3 | $77.77 |
| Aimmune Therapeutics, Inc. | 4 | $75.33 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.